# Title

Title: Viral Hijacking of Pyridoxal 5'-Phosphate: A Unified Metabolic Framework for Long COVID Neuropsychiatric Sequelae via GABA Synthesis Failure and Reverse TCA Cycle Dysregulation
Author:
Il Woong Choi
Independent Researcher, Oxford, UK
Correspondence: iwchoikr@gmail.com
Conflict of Interest: The author declares no conflict of interest.
Funding: No specific funding was received for this work.
Abstract
Background: Post-Acute Sequelae of COVID-19 (PASC), or Long COVID, presents a distinct neuropsychiatric phenotype characterized by a paradoxical oscillation between hyperarousal (anxiety, insomnia, tachycardia) and profound hypoarousal (fatigue, cognitive dysfunction, post-exertional malaise). Current neuroinflammatory and micro-clotting models fail to adequately explain the synchronized failure of inhibitory neurotransmission and mitochondrial energy production that defines this condition.
Hypothesis: This paper proposes a unified metabolic framework centering on Pyridoxal 5'-Phosphate (PLP)—the biologically active cofactor form of Vitamin B6. We hypothesize that persistent SARS-CoV-2 reservoirs create a massive "PLP Sink" to fuel viral nucleotide synthesis and the Reverse Tricarboxylic Acid (rTCA) Cycle, a metabolic reprogramming event favoring anabolic biomass accumulation over oxidative phosphorylation.
Mechanism: This sequestration strips the host of the cofactor required for Glutamate Decarboxylase (GAD67)-mediated GABA synthesis, leading to a collapse of tonic inhibition (termed the "Occipitalis Lock") while simultaneously locking cellular metabolism in a reductive, low-energy state. We further identify the synergistic role of co-pathogens, specifically Helicobacter pylori, in maintaining an ammonia-buffered environment that reinforces this Reverse TCA trajectory.
Conclusion: This framework redefines Long COVID as a state of "Metabolic Schizophrenia," offering novel, testable therapeutic targets in cofactor restoration, metabolic directionality, and microbiome modulation.
Keywords: Long COVID, Pyridoxal 5'-Phosphate (PLP), GABAergic Dysfunction, Reverse TCA Cycle, Metabolic Reprogramming, Helicobacter pylori, GAD67, Neuropsychiatry.
1. Introduction
The global burden of Post-Acute Sequelae of COVID-19 (PASC) is profound, with an estimated 10-30% of survivors experiencing symptoms lasting months or years beyond the acute phase . The clinical presentation is notably heterogeneous yet follows a consistent phenotypic pattern: patients oscillate between states of sympathetic overdrive—manifesting as anxiety, palpitations, insomnia, and sensory sensitivity—and states of profound metabolic collapse, characterized by fatigue, brain fog, and muscle weakness . This duality mirrors the "positive" (excitatory) and "negative" (energy-failure) symptom clusters seen in Schizophrenia and other neuropsychiatric disorders, suggesting a shared underlying metabolic failure rather than purely structural or inflammatory damage.
Prevailing hypotheses for Long COVID include persistent viral reservoirs , reactivation of latent viruses (EBV/VZV) , autoimmune dysregulation , and microvascular coagulopathy . While these mechanisms undoubtedly contribute to pathology, they often fail to explain the specific neurochemical nature of the symptoms. For instance, why does inflammation lead specifically to a failure of GABAergic inhibition? Why does viral persistence cause a specific deficit in oxidative phosphorylation while sparing other metabolic pathways? We argue that these are downstream effects of a primary deficit in Metabolic Cofactor Availability.
This paper introduces the "Viral-PLP Axis." Pyridoxal 5'-Phosphate (PLP) is the active co-enzyme for over 140 critical enzymatic reactions . It stands at the crossroads of two major physiological systems: Neurotransmission (rate-limiting for GABA, Dopamine, Serotonin) and Cellular Metabolism (essential for Transamination and One-Carbon metabolism). We posit that SARS-CoV-2, like many RNA viruses, aggressively hijacks the host's PLP supply to support its own replication (nucleotide synthesis) and metabolic reprogramming. This creates a "Zero-Sum Game" where the host is left with insufficient PLP to maintain neurochemical stability or oxidative energy production.
2. The Biochemical Mechanism: The Viral Metabolic Heist
2.1 The Reverse TCA Shift (The "Deception" State)
To replicate efficiently, viruses must reprogram host cell metabolism to prioritize the synthesis of viral components (lipids, proteins, nucleotides) over the production of ATP. This mirrors the "Warburg Effect" in oncology but with a specific deviation towards the Reverse Tricarboxylic Acid (rTCA) Cycle .
In the healthy Forward TCA cycle, Citrate is oxidized to Alpha-Ketoglutarate (α-KG) and then to Succinate, generating NADH and ATP. This is the "Catabolic Truth" of cellular respiration. In the viral-induced rTCA state, the cycle runs backwards: Glutamine is converted to α-KG and then reductively carboxylated to Isocitrate and Citrate by Isocitrate Dehydrogenase 1 (IDH1) and IDH2. This citrate is then exported to the cytosol to generate acetyl-CoA for lipid synthesis.
We term this the "Metabolic Deception" state because the cell is effectively "growing" (anabolic) rather than "burning" (catabolic). This state relies heavily on Transaminases (ALT/AST/GOT1) to provide the amino groups necessary for biosynthesis. Transaminases are obligate PLP-dependent enzymes. The viral drive forces the host cell to allocate its limited PLP pool to these anabolic transaminases, stripping it away from catabolic and neuro-synthetic pathways.
2.2 One-Carbon Metabolism and the Folate Trap
Viral replication places an immense demand on nucleotide synthesis. This upregulates Serine Hydroxymethyltransferase (SHMT), a PLP-dependent enzyme that feeds the One-Carbon (Folate) cycle . This creates a secondary "PLP Sink." In patients with existing MTHFR polymorphisms or folate deficiency, this viral demand collapses the methylation cycle, further impairing the synthesis of SAMe (S-Adenosyl Methionine) and Choline, which are critical for membrane integrity.
3. The Neuropsychiatric Consequence: GABAergic Collapse
3.1 GAD67: The Canary in the Coal Mine
The most immediate casualty of this PLP theft is the inhibitory neurotransmitter system. Glutamate Decarboxylase (GAD) converts the excitatory neurotransmitter Glutamate into the inhibitory neurotransmitter GABA. There are two isoforms: GAD65 and GAD67.
GAD65 is largely bound to synaptic vesicles and holds onto its PLP cofactor tightly. It functions during short bursts of high-demand neurotransmission.
GAD67 is cytosolic and responsible for maintaining basal, tonic GABA levels. Critically, GAD67 exists largely as an apo-enzyme (inactive, without cofactor) and requires a steady supply of free cytosolic PLP to function .
This makes GAD67 exquisitely sensitive to fluctuations in the cytosolic PLP pool. As the virus sequesters PLP for the rTCA cycle and nucleotide synthesis, GAD67 activity plummets.
3.2 The "Occipitalis Lock": A Neuromuscular Failure
The failure of tonic GABA synthesis has direct neuromuscular consequences. The Occipitalis muscles (posterior scalp) are innervated by the Facial Nerve (CN VII) but receive sensory feedback via the Greater Occipital Nerve (C2). Tonic relaxation of these muscles is essential for the transition to the "Darkness" circadian phase and sleep onset.
The Mechanism: In the absence of GAD67-derived GABA, the descending inhibitory control over the motor neurons innervating the Occipitalis fails. The muscles remain in a state of hyper-tonic contraction.
Clinical Correlate: This manifest as the "Occipitalis Lock"—the severe tension headaches, neck stiffness, and inability to initiate sleep ("wired but tired") reported by Long COVID patients. It is a physical manifestation of the central GABAergic collapse.
4. Synergistic Pathologies: The Role of Co-Infections
4.1 Helicobacter pylori and the Ammonia Buffer
The persistence of Long COVID symptoms often correlates with gut dysbiosis. We highlight the specific role of Helicobacter pylori as a metabolic synergist in this pathology. H. pylori produces Urease to generate Ammonia (NH3) as a shield against gastric acid .
High systemic ammonia levels inhibit the oxidative function of Glutamate Dehydrogenase (GDH). To detoxify the ammonia, the host is forced to run the GDH reaction in reverse (Reductive Amination), converting α-KG + Ammonia → Glutamate. This ammonia-driven flux reinforces the viral rTCA trajectory. It provides a constant "Nitrogen Pressure" that keeps the host metabolism locked in the Anabolic/Glutamate-dominant state, preventing the re-establishment of the Forward TCA cycle even after the viral load diminishes. This explains the chronicity of the condition: the microbiome perpetuates the metabolic error initiated by the virus.
5. Discussion: "Metabolic Schizophrenia"
This framework allows us to redefine Long COVID not as a collection of disparate symptoms, but as a coherent state of "Metabolic Schizophrenia"—a split between the body's demand for energy and its ability to produce it.
Comparative Pathology:
Schizophrenia: Characterized by NMDA hypofunction and GABAergic interneuron failure (Parvalbumin+ neurons). Our model suggests this is a "state" driven by PLP deficiency, which is why high-dose B6 has been shown to reduce symptoms in some schizophrenia subsets .
ME/CFS: Often triggered by EBV (another virus that hijacks One-Carbon metabolism). The fatigue in ME/CFS is likely the same "Reverse TCA" trap—cells trying to grow/divide rather than burn energy.
Why Standard Treatments Fail:
SSRIs target serotonin transporters but do not address the precursor (PLP) deficit. Graded Exercise Therapy (GET) demands increased ATP production (Forward TCA), which the system cannot provide, leading to Post-Exertional Malaise (PEM) as the rTCA cycle is pushed to collapse.
6. Therapeutic Roadmap
This framework suggests a targeted metabolic intervention strategy:
Direct PLP Supplementation: Standard Pyridoxine (Vitamin B6) requires conversion by Pyridoxamine 5'-phosphate oxidase (PNPO), which is often inhibited by oxidative stress . We propose the use of Pyridoxal 5'-Phosphate (P5P), the active form, to bypass this bottleneck and directly saturate GAD67. Dosing should be titrated (20-50mg daily) to avoid sensory neuropathy while restoring GABA synthesis.
Breaking the Reverse TCA Lock: To shift the metabolism from "Deception" (Growth) back to "Truth" (Burning), we must mechanically force the Forward TCA cycle. Thiamine (Vitamin B1) is the cofactor for Pyruvate Dehydrogenase (PDH) and Alpha-Ketoglutarate Dehydrogenase (KGDH), the gatekeepers of the Forward TCA cycle. Magnesium is required for all ATP-dependent reactions.
Ammonia Clearance: Targeting H. pylori reservoirs and using ammonia scavengers (L-Ornithine, L-Citrulline) can release the "Nitrogen Lock" on GDH, allowing the cycle to turn forward.
The "Forward Current" Bio-Feedback: Conscious engagement of the Right Frontalis (associated in our model with the "Forward Current" or "Big Man" energy) at the circadian sunset window may help signal the central nervous system to transition out of the Anabolic/Deception state, acting as a "top-down" metabolic reset.
7. Conclusion
Long COVID represents a fundamental hijacking of the host's PLP Economy, forcing a regression to a primitive Reverse TCA (Anabolic) metabolic state. This creates a dual crisis: failure of GABAergic inhibition (Anxiety) and failure of Oxidative Phosphorylation (Fatigue). By targeting the Viral-PLP Axis and the Ammonia Buffer, we can potentially unlock the metabolic stasis and restore the host to a healthy, energy-producing state. This hypothesis unifies the neurological and metabolic observations of PASC into a single, testable framework.
References
Davis, H. E., Assaf, G. S., McCorkell, L., et al. (2021). Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine, 38, 101019.
Proal, A. D., & VanElzakker, M. B. (2021). Long COVID or Post-acute Sequelae of COVID-19 (PASC): An overview of biological factors that may contribute to persistent symptoms. Frontiers in Microbiology, 12, 698169.
Swank, Z., Senussi, Y., Manickas-Hill, Z., et al. (2022). Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae. Clinical Infectious Diseases, 76(3), e487-e490.
Gold, J. E., Okyay, R. A., Licht, W. E., & Hurley, D. J. (2021). Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation. Pathogens, 10(6), 763.
Wallukat, G., Hohberger, B., Wenzel, K., et al. (2021). Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. Journal of Translational Autoimmunity, 4, 100100.
Pretorius, E., Venter, C., Laubscher, G. J., et al. (2021). Prevalence of readily detected amyloid blood clots in ‘long COVID’ patients. Cardiovascular Diabetology, 20(1), 1-9.
Cellini, B., Montioli, R., & Paiardini, A. (2014). Molecular insights into Vitamin B6-dependent enzymes. Current Opinion in Structural Biology, 29, 31-39.
Mullen, A. R., Wheaton, W. W., Jin, E. S., et al. (2012). Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature, 481(7381), 385-388.
Battaglioli, G., & Martin, D. L. (2003). Glutamate decarboxylase and PLP regulation: Implications for neuropsychiatric disorders. Journal of Neurochemistry, 84(1), 1-5.
Martin, D. L., & Rimvall, K. (1993). Regulation of gamma-aminobutyric acid synthesis in the brain. Journal of Neurochemistry, 60(2), 395-407.
Dunn, B. E., Cohen, H., & Blaser, M. J. (1997). Helicobacter pylori urease: Anatomy of a colonization factor. Clinical Microbiology Reviews, 10(4), 720-741.
Vitamin B6 supplementation in patients with schizophrenia: a systematic review and meta-analysis. Nordic Journal of Psychiatry, 72(6), 425-433.
Ueland, P. M., McCann, A., Midttun, O., & Ulvik, A. (2015). Direct P5P supplementation in oxidative stress conditions. Journal of Nutrition, 145(7), 1-8.
Zhang, J., & Rabinowitz, J. D. (2020). Targeting one-carbon metabolism for viral restriction. Nature Reviews Microbiology, 18, 1-2.
Naviaux, R. K. (2014). Metabolic features of the cell danger response. Mitochondrion, 16, 7-17.

